Abstract
A nosocomial outbreak of epidemiologically related VEB-1 extended-spectrum beta-lactamase-producing isolates of Acinetobacter baumannii occurred in 33 patients in an intensive care unit. A case-control study identified previous treatment with third-generation cephalosporins as the only risk factor for A. baumannii acquisition. Rationale for antibiotic use should be strengthened.
MeSH terms
-
Acinetobacter Infections / epidemiology*
-
Acinetobacter Infections / microbiology
-
Acinetobacter Infections / prevention & control
-
Acinetobacter baumannii* / enzymology
-
Acinetobacter baumannii* / genetics
-
Acinetobacter baumannii* / isolation & purification
-
Aged
-
Anti-Bacterial Agents / adverse effects
-
Bacterial Typing Techniques
-
Case-Control Studies
-
Cephalosporins / adverse effects
-
Cluster Analysis
-
Cross Infection / epidemiology*
-
Cross Infection / microbiology
-
Cross Infection / prevention & control
-
DNA, Bacterial / analysis
-
DNA, Bacterial / genetics
-
Disease Outbreaks / prevention & control
-
Disease Outbreaks / statistics & numerical data*
-
Drug Utilization
-
Electrophoresis, Gel, Pulsed-Field
-
Escherichia coli Proteins
-
Female
-
France / epidemiology
-
Humans
-
Infection Control / methods
-
Intensive Care Units
-
Logistic Models
-
Male
-
Microbial Sensitivity Tests
-
Middle Aged
-
Multivariate Analysis
-
Phylogeny
-
Polymerase Chain Reaction
-
Risk Factors
-
Time Factors
-
beta-Lactam Resistance / genetics
-
beta-Lactamases* / biosynthesis
Substances
-
Anti-Bacterial Agents
-
Cephalosporins
-
DNA, Bacterial
-
Escherichia coli Proteins
-
beta-lactamase VEB-1, E coli
-
beta-Lactamases